©2022-2032 All Rights Reserved. Online Journal of Veterinary Research . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the  before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJVR publications. This article may be copied once but may not be, reproduced or  re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.

OJVRTM

Online Journal of Veterinary Research©

(Including Medical and Laboratory Research)

Established 1994
ISSN 1328-925X

 

Volume 26 (12): 866-879, 2022.

 

Drug targets for Chlamydophila pneumoniae

 

Reddy EH,  Satpathy GR

 

1Department of Biotechnology and Medical Engineering, National Insitute of Technology, Rourkela, India.

 

ABSTRACT

 

Reddy EH,  Satpathy GR., Drug targets for Chlamydophila pneumoniae, Onl J Vet Res., 26 (12): 866-879, 2022. Whole genome sequences of Chlamydophila pneumoniae and four strains were analyzed to identify common drug targets. A substractive genomic approach was done to identify Holliday junction DNA helicase RuvB as common non-human homologous gene amongst the four strains. A 3D model of Holliday junction DNA helicase RuvB protein was generated by homology modelling with most likely ligands selected by biological and chemical properties interaction with target proteins. Docking was done with the different conformations of each ligand. Two lead molecules for designing drugs against the pathogen were identified by considering the physical and chemical aspects of their binding to the protein. In this paper, we predicted Holliday junction DNA helicase RuvB protein as novel drug target and by inhibiting its activity we can control the pneumonia. This in silico analysis provides a rapid and potential approach for the identification of drug targets and design of drug lead molecules.

 

Keywords: Chlamydophila pneumoniae, homology modeling, drug targets, docking, drug design.

MAIN

 

FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)